MedTrace Logo

VIGAB-BIOSTAT: Neuronal Injury Panel Substudy

NCT05000320 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-01-05

No results posted yet for this study

Summary

The purpose of this substudy is to collect and analyze control data to characterize the degree of neuronal injury in PASE patients who have not received vigabatrin to later compare with patients who received this therapy and expand data on the utility of the neuronal injury panel for neuroprognostication. Data from this cohort will be compared with the data generated by the treatment cohort in the main VIGAB-STAT study.

Conditions

  • Status Epilepticus
  • Cardiac Arrest With Successful Resuscitation

Interventions

DIAGNOSTIC_TEST

Neuronal Injury Panel

A panel of neuronal and astroglial assays that may be a marker of brain injury.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Carolina Maciel, MD, MSCR · University of Florida

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2024-08-17
Completion
2024-08-17

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05000320 on ClinicalTrials.gov